Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jan;40(1):391-9.
doi: 10.1007/s11033-012-2073-2. Epub 2012 Oct 9.

Expression profiles of Th17 pathway related genes in human systemic lupus erythematosus

Affiliations

Expression profiles of Th17 pathway related genes in human systemic lupus erythematosus

Hai-Feng Pan et al. Mol Biol Rep. 2013 Jan.

Abstract

Recently, evidence is emerging that inappropriate regulation of type 17 T helper cells (Th17) plays a fundamental role in the development of many autoimmune diseases including systemic lupus erythematosus (SLE). However, the role of Th17-related cytokines in SLE remains elusive. To further investigate the role and imbalance of Th17-related cytokines in the pathogenesis of SLE. A Quantitative RT-PCR Array (Human Th17 for Autoimmunity & Inflammation PCR Array) analyses were performed to study Th17-related genes expression in peripheral white blood cells of 25 new-onset patients with SLE and 15 healthy subjects. When gene expression for SLE patients was compared to the mean of normal controls, among the 84 target genes related to Th17 pathway, 7 (CXCL1, ICAM1, IL10, IL5, IL8, ISG20, JAK2,) were upregulated and 6 (CD28, CD40LG, S1PR1, IL17RE, IL23R, RORC) downregulated. However, comparisons of mRNA expression of Th17 related cytokines between lupus nephritis (LN) patients and SLE patients without nephritis (SLE non LN) showed no significant difference. In conclusion, SLE patients and normal controls showed different expression of a few genes in Th17 pathway, indicating that the pathway may be involved in the pathogenesis of SLE.

PubMed Disclaimer

References

    1. Clin Immunol. 2008 Jun;127(3):385-93 - PubMed
    1. Rheumatol Int. 2011 Oct;31(10):1321-1324 - PubMed
    1. J Immunol. 2010 Sep 1;185(5):2675-9 - PubMed
    1. Arthritis Rheum. 2000 Nov;43(11):2455-63 - PubMed
    1. J Biomed Biotechnol. 2010;2010:838390 - PubMed

Publication types

LinkOut - more resources